These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1820705)

  • 21. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
    Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite.
    Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S
    Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
    Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
    J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
    Vanderberg JP; Khan ZM; Stewart MJ
    J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
    J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective and pathogenic roles of CD8+ T cells during malaria infection.
    Hafalla JC; Cockburn IA; Zavala F
    Parasite Immunol; 2006; 28(1-2):15-24. PubMed ID: 16438672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera.
    Mohmmed A; Kishore S; Patra KP; Dasaradhi PV; Malhotra P; Chauhan VS
    Parasite Immunol; 2005 May; 27(5):197-203. PubMed ID: 15987343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.
    Bate CA; Taverne J; Playfair JH
    Immunology; 1989 Apr; 66(4):600-5. PubMed ID: 2654012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malarial parasites induce TNF production by macrophages.
    Bate CA; Taverne J; Playfair JH
    Immunology; 1988 Jun; 64(2):227-31. PubMed ID: 3292408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.
    Bate CA; Taverne J; Davé A; Playfair JH
    Immunology; 1990 Jul; 70(3):315-20. PubMed ID: 2379940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium antigens external to the parasite but with the infected erythrocyte.
    Wiser MF
    Parasitol Res; 1989; 75(3):206-11. PubMed ID: 2652137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An antigen specific to the liver stage of rodent malaria recognized by a monoclonal antibody.
    Suhrbier A; Winger L; O'Dowd C; Hodivala K; Sinden RE
    Parasite Immunol; 1990 Sep; 12(5):473-81. PubMed ID: 2255559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice.
    Elased KM; Taverne J; Playfair JH
    Clin Exp Immunol; 1996 Sep; 105(3):443-9. PubMed ID: 8809132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipid-containing toxic malaria antigens induce hypoglycaemia.
    Taylor K; Bate CA; Carr RE; Butcher GA; Taverne J; Playfair JH
    Clin Exp Immunol; 1992 Oct; 90(1):1-5. PubMed ID: 1395089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.
    Taverne J; Bate CA; Kwiatkowski D; Jakobsen PH; Playfair JH
    Infect Immun; 1990 Sep; 58(9):2923-8. PubMed ID: 2201638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination against malaria.
    Phillips RS
    Immunobiology; 1992 Feb; 184(2-3):240-62. PubMed ID: 1587546
    [No Abstract]   [Full Text] [Related]  

  • 38. Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.
    Bate CA; Taverne J; Playfair JH
    Infect Immun; 1992 May; 60(5):1894-901. PubMed ID: 1563780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steps towards a malaria vaccine.
    Hommel M
    Res Immunol; 1991 Oct; 142(8):618-31. PubMed ID: 1817288
    [No Abstract]   [Full Text] [Related]  

  • 40. The multifactorial character of the protective immunity induced by immunization with sporozoites.
    Zavala F
    Res Immunol; 1991 Oct; 142(8):654-8. PubMed ID: 1817293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.